Clinical Trial Update: Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and safety of autologous dendritic cell vaccination in glioblastoma multiforme after complete surgical resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Autologous dendritic cell vaccination

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED